News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Retroscreen Virology Limited Purchases ALPHADAS for Clinical Studies Across Multiple Sites



7/31/2013 10:00:05 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that the operating subsidiary of Retroscreen Virology Group PLC (AIM: RVG, “Retroscreen”) has purchased the ALPHADAS® clinical trials software suite to assist in its mission to accelerate and reduce the cost of bringing anti-viral drugs, diagnostics, and vaccines to market.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES